Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yunyu, Feng"'
Autor:
Qiang Qiu, Yuanyuan Sun, Linyu Yang, Qingqing Li, Yunyu Feng, Mengyuan Li, Yuexia Yin, Li Zheng, Ning Li, Huandi Qiu, Xue Cui, Wei He, Bochuan Wang, Cong Pan, Zi Wang, Juan Huang, Klarke M. Sample, Zhihui Li, Yiguo Hu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-14 (2023)
Abstract We report herein that TSPAN32 is a key node factor for Philadelphia (Ph+) leukemia pathogenesis. We found that TSPAN32 expression was repressed by BCR-ABL and ectopic TSPAN32 expression upon Imatinib treatment inhibited the proliferation of
Externí odkaz:
https://doaj.org/article/21964beafc5b4db68d3f5622b80d2d22
Autor:
Qiang Qiu, Linyu yang, Yunyu Feng, Zejiang Zhu, Ning Li, Li Zheng, Yuanyuan Sun, Cong Pan, Huandi Qiu, Xue Cui, Wei He, Fang Wang, Yuyao Yi, Minghai Tang, Zhuang Yang, Yunfan Yang, Zhihui Li, Lijuan Chen, Yiguo Hu
Publikováno v:
Bioactive Materials, Vol 21, Iss , Pp 483-498 (2023)
Purinostat Mesylate (PM) is a novel highly selective and active HDAC I/IIb inhibitor, and the injectable formulation of PM (PMF) based on the compound prescription containing cyclodextrin completely can overcome PM's poor solubility and improves its
Externí odkaz:
https://doaj.org/article/0d7da28d05d149efa099f6bd699967a1
Autor:
Cheng Huang, Xing Duan, Jichao Wang, Qingqing Tian, Yangmei Ren, Kepan Chen, Zongliang Zhang, Yuanyou Li, Yunyu Feng, Kunhong Zhong, Yuelong Wang, Liangxue Zhou, Gang Guo, Xiangrong Song, Aiping Tong
Publikováno v:
Advanced Science, Vol 10, Iss 3, Pp n/a-n/a (2023)
Abstract The therapeutic use of bispecific T‐cell engaging (BiTE) antibodies has shown great potential for treating malignancies. BiTE can simultaneously engage CD3ε on T cells and tumor antigen on cancer cells, thus exerting an effective antitumo
Externí odkaz:
https://doaj.org/article/3b8220cd38bb4722bfc4aff980f617da
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253329 (2021)
The global pandemic of COVID-19 poses a huge threat to the health and lives of people all over the world, and brings unprecedented pressure to the medical system. We need to establish a practical method to improve the efficiency of treatment and opti
Externí odkaz:
https://doaj.org/article/a6a31ea90d6349709930e3c32d407e36
Autor:
Hongjian Li, Cheng Huang, Zongliang Zhang, Yunyu Feng, Zeng Wang, Xin Tang, Kunhong Zhong, Yating Hu, Gang Guo, Liangxue Zhou, Wenhao Guo, Jianguo Xu, Hui Yang, Aiping Tong
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Targeting cancer antigens by T cell-engaging bispecific antibody (BiAb) or chimeric antigen receptor T cell therapy has achieved successes in hematological cancers, but attempts to use it to fight solid cancers have been disappointing, in part due to
Externí odkaz:
https://doaj.org/article/3e562fb1477649b9851aba7a78fb51c7
Autor:
Ning, Li, Nan, Wang, Wei, He, Yunyu, Feng, Qiang, Qiu, Huandi, Qiu, Li, Zheng, Yuexia, Yin, Bochuan, Wang, Yuanyuan, Sun, Cong, Pan, Klarke M, Sample, Juan, Huang, Zhiguang, Su, Zhihui, Li, Haojian, Zhang, Yiguo, Hu
Publikováno v:
International Journal of Biological Sciences. 18:2277-2291
RORA plays an important role in regulating circadian rhythms, inflammation, metabolism and cellular development. Herein, we explore the roles of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c08fad5cab9789b10543b8c145dd0f4e
https://doi.org/10.7150/ijbs.68939
https://doi.org/10.7150/ijbs.68939
Autor:
Li Zheng, Cong Pan, Wanli Tian, Cailing Liang, Yunyu Feng, Wei He, Zirong Yang, Bochuan Wang, Qiang Qiu, Ning Li, Yuanyuan Sun, Huandi Qiu, Klarke M. Sample, Lingyun Zhou, Xianjun Zhu, Yiguo Hu
Publikováno v:
Cellular Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be74f1c2844c96936e56a38172c6c2ab
https://doi.org/10.1007/s13402-023-00797-7
https://doi.org/10.1007/s13402-023-00797-7
Autor:
Cheng Huang, Xing Duan, Jichao Wang, Qingqing Tian, Yangmei Ren, Kepan Chen, Zongliang Zhang, Yuanyou Li, Yunyu Feng, Kunhong Zhong, Yuelong Wang, Liangxue Zhou, Gang Guo, Xiangrong Song, Aiping Tong
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany).
The therapeutic use of bispecific T-cell engaging (BiTE) antibodies has shown great potential for treating malignancies. BiTE can simultaneously engage CD3ε on T cells and tumor antigen on cancer cells, thus exerting an effective antitumor effect. N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e39e27a243cd962a96156de5c66e45
https://pubmed.ncbi.nlm.nih.gov/36403209
https://pubmed.ncbi.nlm.nih.gov/36403209
Autor:
Qiang Qiu, Linyu yang, Yunyu Feng, Zejiang Zhu, Ning Li, Li Zheng, Yuanyuan Sun, Cong Pan, Huandi Qiu, Xue Cui, Wei He, Fang Wang, Yuyao Yi, Minghai Tang, Zhuang Yang, Yunfan Yang, Zhihui Li, Lijuan Chen, Yiguo Hu
Publikováno v:
Bioactive materials. 21
Purinostat Mesylate (PM) is a novel highly selective and active HDAC I/IIb inhibitor, and the injectable formulation of PM (PMF) based on the compound prescription containing cyclodextrin completely can overcome PM's poor solubility and improves its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a36eeb44e1c54e03160aa6d0ef3d1b3
https://pubmed.ncbi.nlm.nih.gov/36185739
https://pubmed.ncbi.nlm.nih.gov/36185739
Autor:
Yuying Fu, Caiying Jiang, Aiping Tong, Huan Hou, Wenhao Guo, Hui Yang, Yunyu Feng, Shasha Zhao, Gang Guo, Zongliang Zhang, Jichao Wang, Yi Kuang, Zeng Wang, Cheng Huang, Chenli Yang, Liangxue Zhou, Xiaoling Li, Yuelong Wang, Min Mu, Jianguo Xu, Hongjian Li
Publikováno v:
Theranostics
Rationale: Current traditional treatment options are frequently ineffective to fight against ovarian cancer due to late diagnosis and high recurrence. Therefore, there is a vital need for the development of novel therapeutic agents. B7H3, an immune c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce2fab528cfa93f5ac793a23a755024e
https://doi.org/10.7150/thno.49480
https://doi.org/10.7150/thno.49480